Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1235 |
|
| Actual shortage: | 52 (4%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1147 (93%) | |
Discontinuation Reports |
284 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 283 (100%) | |
| Reversed: | 1 (0%) | |
Late reports |
205 (13%) |
|
Overdue reports |
13 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2022-01-27 | 2022-02-07 | 153643 |
| PMS-QUETIAPINE | 50MG | TABLET | Resolved | 2022-01-27 | 2022-03-04 | 153646 |
| PMS-SULFASALAZINE 500MG/TAB USP | 500MG | TABLET | Resolved | 2022-03-18 | 2022-05-25 | 156960 |
| PHARMA-LACOSAMIDE | 50MG | TABLET | Resolved | 2022-06-22 | 2022-09-06 | 163281 |
| PHARMA-SIMVASTATIN | 10MG | TABLET | Resolved | 2022-07-29 | 2023-01-27 | 165653 |
| PMS-TADALAFIL | 10MG | TABLET | Resolved | 2022-08-15 | 2022-12-01 | 166794 |
| PMS-ENTECAVIR | 0.5MG | TABLET | Resolved | 2022-08-15 | 2022-09-15 | 166799 |
| PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 600MG 300MG 200MG | TABLET | Resolved | 2022-08-15 | 2022-10-24 | 166805 |
| PMS-EVEROLIMUS | 2.5MG | TABLET | Resolved | 2022-08-15 | 2023-06-09 | 166808 |
| PMS-TERAZOSIN | 5MG | TABLET | Resolved | 2022-09-06 | 2022-09-30 | 168634 |
| PMS-TERAZOSIN | 10MG | TABLET | Resolved | 2022-09-06 | 2022-10-27 | 168637 |
| PMS-QUINAPRIL | 10MG | TABLET | Resolved | 2022-09-27 | 2023-05-17 | 170269 |
| PMS-QUINAPRIL | 20MG | TABLET | Resolved | 2022-09-27 | 2023-05-17 | 170272 |
| PMS-QUINAPRIL | 40MG | TABLET | Resolved | 2022-09-27 | 2023-12-23 | 170275 |
| PMS-BETAHISTINE | 16MG | TABLET | Actual shortage | 2022-09-27 | 2022-10-28 | 170278 |
| PMS-BETAHISTINE | 24MG | TABLET | Actual shortage | 2022-09-27 | 2022-11-25 | 170281 |
| PHARMA-LACOSAMIDE | 50MG | TABLET | Resolved | 2022-09-30 | 2022-11-21 | 170591 |
| PMS-LAMOTRIGINE | 100MG | TABLET | Resolved | 2022-10-14 | 2023-01-06 | 171762 |
| PMS-LAMOTRIGINE | 150MG | TABLET | Resolved | 2022-10-14 | 2022-12-01 | 171765 |
| PMS-QUINAPRIL | 5MG | TABLET | Resolved | 2022-10-28 | 2023-05-17 | 172827 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118153 |
| PMS-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118156 |
| PMS-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118159 |
| PMS-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-07-25 | 2022-07-25 | 165469 |